Read news on cancer vaccine with our app.
Read more in the app
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
mRNA cancer vaccine triggers fierce immune response to fight brain tumors
